<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39309070</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6973</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Infection and drug resistance</Title><ISOAbbreviation>Infect Drug Resist</ISOAbbreviation></Journal><ArticleTitle>Hematocrit and Albumin Levels at Admission Predict in-Hospital Mortality in Pediatric COVID-19 Omicron Variant Patients.</ArticleTitle><Pagination><StartPage>4067</StartPage><EndPage>4078</EndPage><MedlinePgn>4067-4078</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IDR.S479580</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">The Omicron variant is the present predominant COVID-19 strain worldwide. Accurate mortality prediction can facilitate risk stratification and targeted therapies. The study aimed to evaluate the feasibility of the difference in hematocrit and albumin (HCT-ALB) levels, alone or combined with the pediatric Sequential Organ Failure Assessment (pSOFA) score and lactate level, to predict the in-hospital mortality of COVID-19 Omicron variant-infected pediatric patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A multicenter retrospective cohort study was performed for children with COVID-19 Omicron variant infection between December 2021 and January 2022. The demographics, clinical characteristics, hospital admission laboratory test results, and treatments were recorded. The in-hospital mortality was documented. The associations between HCT-ALB levels and mortality, and between HCT-ALB+pSOFA+lactate and mortality were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 119 children were included. The median age was 1.6 (interquartile range: 0.5-6.2) years old. There were 70 boys and 49 girls. The mortality rate was 14.3% (17/119). The univariate and multivariate Cox regression analysis revealed that HCT-ALB was associated to in-hospital mortality (hazard ratio: 1.500, 95% confidence interval: 1.235-1.822, <i>p</i>&lt;0.001). The receiver operating characteristic curve analysis revealed that HCT-ALB can be used to accurately predict in-hospital mortality at a cut-off value of -0.7 (area under the curve: 0.888, sensitivity: 0.882, specificity: 0.225, Youden index: 0.657, <i>p</i>&lt;0.001). These patients were assigned into three groups based on the HCT-ALB level, pSOFA score, and lactate level (low-, medium-, and high-risk groups). The Kaplan-Meier analysis revealed that the mortality increased in the high-risk group, when compared to the medium-risk group (<i>p</i>&lt;0.01). The latter group had a higher mortality, when compared to the low-risk group (<i>p</i>&lt;0.01).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The HCT-ALB level can be applied to predict the in-hospital mortality of children infected with the COVID-19 Omicron variant. Its combination with other variables can improve prediction performance.</AbstractText><CopyrightInformation>© 2024 Zhu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhu</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care Unit, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Lingyan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Zibo Maternal and Child Health Hospital, Zibo, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Wenxiao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Yantai Yuhuangding Hospital, Yantai, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaodan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care Unit, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Meng Xue</ForeName><Initials>MX</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care Unit, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiumin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Qingzhou People's Hospital, Weifang, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Laizhou City People's Hospital, Laizhou, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Weimei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Haiyang People's Hospital, Haiyang, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Tuo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Jining First People's Hospital, Jining, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jinmei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, West Coast New District Hospital of Chinese Medicine, Huangdao, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lecui</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neonatology, People's Hospital of Wulian, Wulian, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chengjun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Linyi Central Hospital, Linyi, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Zhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Rehabilitation University Qingdao Central Hospital, Qingdao, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Qingdao Traditional Chinese Medicine Hospital, Qingdao, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Dayun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Weihai Municipal Hospital, Weihai, Shangdong, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care Unit, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Drug Resist</MedlineTA><NlmUniqueID>101550216</NlmUniqueID><ISSNLinking>1178-6973</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">albumin</Keyword><Keyword MajorTopicYN="N">hematocrit</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">omicron variant</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39309070</ArticleId><ArticleId IdType="pmc">PMC11416771</ArticleId><ArticleId IdType="doi">10.2147/IDR.S479580</ArticleId><ArticleId IdType="pii">479580</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Suthar AB, Wang J, Seffren V, Wiegand RE, Griffing S, Zell E. Public health impact of covid-19 vaccines in the US: observational study. BMJ. 2022;377:e069317. doi:10.1136/bmj-2021-069317</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069317</ArticleId><ArticleId IdType="pmc">PMC9044401</ArticleId><ArticleId IdType="pubmed">35477670</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MM, Joyce B, Plumb ID, et al. Paxlovid associated with decreased hospitalization rate among adults with COVID-19 - United States, April-September 2022. MMWR Morb Mortal Wkly Rep. 2022;71(48):1531–1537. doi:10.15585/mmwr.mm7148e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7148e2</ArticleId><ArticleId IdType="pmc">PMC9721144</ArticleId><ArticleId IdType="pubmed">36454693</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S, Whittaker C, Semenova E, et al. Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US. JAMA Network Open. 2023;6(1):e2253590. doi:10.1001/jamanetworkopen.2022.53590</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.53590</ArticleId><ArticleId IdType="pmc">PMC9887489</ArticleId><ArticleId IdType="pubmed">36716029</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge SJ, Agrawal U, Murphy S, et al. Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts. Nat Commun. 2024;15(1):2363. doi:10.1038/s41467-024-46451-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-46451-0</ArticleId><ArticleId IdType="pmc">PMC10943015</ArticleId><ArticleId IdType="pubmed">38491011</ArticleId></ArticleIdList></Reference><Reference><Citation>Montarroyos SS, Ladd BF, Mestre M, Cardenas G. Classification of SARS-CoV-2 pediatric hospitalizations: delta vs omicron Variant. Hosp Pediatr. 2023;13(10):940–944. doi:10.1542/hpeds.2023-007136</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/hpeds.2023-007136</ArticleId><ArticleId IdType="pubmed">37777604</ArticleId></ArticleIdList></Reference><Reference><Citation>Head JR, Collender PA, León TM, et al. COVID-19 vaccination and incidence of pediatric SARS-CoV-2 Infection and Hospitalization. JAMA Network Open. 2024;7(4):e247822. doi:10.1001/jamanetworkopen.2024.7822</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.7822</ArticleId><ArticleId IdType="pmc">PMC11040406</ArticleId><ArticleId IdType="pubmed">38652476</ArticleId></ArticleIdList></Reference><Reference><Citation>Paxlovid. Who Can Take PAXLOVID. Who can take paxlovid™ (nirmatrelvir tablets; ritonavir tablets). Available from: https://www.paxlovidinformation.com/. Accessed 16
September 2024.</Citation></Reference><Reference><Citation>Torjesen I. Covid-19: omicron variant is linked to steep rise in hospital admissions of very young children. BMJ. 2022;376:o110. doi:10.1136/bmj.o110</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o110</ArticleId><ArticleId IdType="pubmed">35031537</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed S, Lee J, Bryant A, Choi R, Liegl M, Pan A. Pediatric COVID-19 hospitalizations during the omicron surge. WMJ. 2023;122(5):342–345.</Citation><ArticleIdList><ArticleId IdType="pubmed">38180921</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks KJ, Whitaker M, Agathis NT, et al. Hospitalization of infants and children aged 0-4 years with laboratory-confirmed COVID-19 - COVID-NET, 14 states, march 2020-February 2022. MMWR Morb Mortal Wkly Rep. 2022;71(11):429–436. doi:10.15585/mmwr.mm7111e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7111e2</ArticleId><ArticleId IdType="pmc">PMC8942304</ArticleId><ArticleId IdType="pubmed">35298458</ArticleId></ArticleIdList></Reference><Reference><Citation>Taytard J, Prevost B, Schnuriger A, et al. SARS-CoV-2 B.1.1.529 (Omicron) variant causes an unprecedented surge in children hospitalizations and distinct clinical presentation compared to the SARS-CoV-2 B.1.617.2 (Delta) variant. Front Pediatr. 2022;10:932170. doi:10.3389/fped.2022.932170</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.932170</ArticleId><ArticleId IdType="pmc">PMC9271577</ArticleId><ArticleId IdType="pubmed">35832582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng DC, Liew CH, Tan KK, et al. Risk factors for disease severity among children with Covid-19: a clinical prediction model. BMC Infect Dis. 2023;23(1):398. doi:10.1186/s12879-023-08357-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08357-y</ArticleId><ArticleId IdType="pmc">PMC10259359</ArticleId><ArticleId IdType="pubmed">37308825</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Rodriguez S, Villaverde S, Sanz-Santaeufemia FJ, et al. A bayesian model to predict COVID-19 severity in children. Pediatr Infect Dis J. 2021;40(8):e287–e293. doi:10.1097/INF.0000000000003204</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003204</ArticleId><ArticleId IdType="pubmed">34250967</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JJM, Abbas Q, Liauw F, et al. Development and validation of a clinical predictive model for severe and critical pediatric COVID-19 infection. PLoS One. 2022;17(10):e0275761. doi:10.1371/journal.pone.0275761</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275761</ArticleId><ArticleId IdType="pmc">PMC9612577</ArticleId><ArticleId IdType="pubmed">36301941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Yuan Y, Wang S, et al. Risk profiles of severe illness in children with COVID-19: a meta-analysis of individual patients. Pediatr Res. 2021;90(2):347–352. doi:10.1038/s41390-021-01429-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-021-01429-2</ArticleId><ArticleId IdType="pmc">PMC7984508</ArticleId><ArticleId IdType="pubmed">33753892</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SM, Wu CH, Yen TY, et al. Clinical characteristics and factors associated with severe COVID-19 in hospitalized children during the SARS-CoV-2 Omicron pandemic in Taiwan. J Microbiol Immunol Infect. 2023;56(5):961–969. doi:10.1016/j.jmii.2023.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2023.06.001</ArticleId><ArticleId IdType="pmc">PMC10273769</ArticleId><ArticleId IdType="pubmed">37385831</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravi B, Goebel U, Hassenzahl LO, et al. Capillary leak and endothelial permeability in critically ill patients: a current overview. Intensive Care Med Exp. 2023;11(1):96. doi:10.1186/s40635-023-00582-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-023-00582-8</ArticleId><ArticleId IdType="pmc">PMC10733291</ArticleId><ArticleId IdType="pubmed">38117435</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai DM, Wang D, Hu D, et al. Difference in hematocrit and plasma albumin levels as an additional biomarker in the diagnosis of infectious disease. Arch Med Sci. 2020;16(3):522–530. doi:10.5114/aoms.2019.86898</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms.2019.86898</ArticleId><ArticleId IdType="pmc">PMC7212220</ArticleId><ArticleId IdType="pubmed">32399098</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhang L, Li S, et al. The relationship between hematocrit and serum albumin levels difference and mortality in elderly sepsis patients in intensive care units-a retrospective study based on two large database. BMC Infect Dis. 2022;22(1):629. doi:10.1186/s12879-022-07609-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07609-7</ArticleId><ArticleId IdType="pmc">PMC9295343</ArticleId><ArticleId IdType="pubmed">35850582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai DM, Cao J, Yang HM, et al. Hematocrit and plasma albumin levels difference may be a potential biomarker to discriminate preeclampsia and eclampsia in patients with hypertensive disorders of pregnancy. Clin Chim Acta. 2017;464:218–222. doi:10.1016/j.cca.2016.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2016.12.001</ArticleId><ArticleId IdType="pubmed">27919602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosalem O, Hernandez Garcilazo N, Saleh Y, Abu Rous F. Pulmonary embolism as the primary presentation of IgA vasculitis. BMJ Case Rep. 2020;13(8):e235884. doi:10.1136/bcr-2020-235884</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-235884</ArticleId><ArticleId IdType="pmc">PMC7454181</ArticleId><ArticleId IdType="pubmed">32859624</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JX, Liao PL, Wei JC, Hsu SB, Yeh CJ. A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the delta and omicron waves in the United States: a retrospective cohort study. Front Public Health. 2023;11:1143650. doi:10.3389/fpubh.2023.1143650</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1143650</ArticleId><ArticleId IdType="pmc">PMC10548482</ArticleId><ArticleId IdType="pubmed">37799149</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023;64(1):90–107. doi:10.1007/s12016-022-08921-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JH, Choi SH, Yun KW. Risk factors for severe COVID-19 in children: a systematic review and meta-analysis. J Korean Med Sci. 2022;37(5):e35. doi:10.3346/jkms.2022.37.e35</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e35</ArticleId><ArticleId IdType="pmc">PMC8822112</ArticleId><ArticleId IdType="pubmed">35132841</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai D, Hu R, Xu W, et al. Feasibility study of the difference between hematocrit and albumin for identifying hemorrhagic shock and septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30(12):1137–1140. doi:10.3760/cma.j.issn.2095-4352.2018.012.007</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.2095-4352.2018.012.007</ArticleId><ArticleId IdType="pubmed">30592946</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Hu R, Wang Y, et al. Feasibility of difference between hematocrit and albumin for identifying severity of scrub typhus disease. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(12):1527–1530. doi:10.3760/cma.j.issn.2095-4352.2019.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.2095-4352.2019.12.018</ArticleId><ArticleId IdType="pubmed">32029042</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo R, Xie Y, Zhang W, Hu R, Zheng F. Clinical research of the differences between hematocrit and serum albumin for evaluating the severity of acute paraquat poisoning. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021;33(8):999–1002. doi:10.3760/cma.j.cn121430-20201022-00682</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn121430-20201022-00682</ArticleId><ArticleId IdType="pubmed">34590571</ArticleId></ArticleIdList></Reference><Reference><Citation>Liuzzo G, Patrono C. COVID 19: in the eye of the cytokine storm. Eur Heart J. 2021;42(2):150–151. doi:10.1093/eurheartj/ehaa1005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa1005</ArticleId><ArticleId IdType="pmc">PMC7799110</ArticleId><ArticleId IdType="pubmed">33462598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75(1):25–36. doi:10.4097/kja.21209</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kja.21209</ArticleId><ArticleId IdType="pmc">PMC8831439</ArticleId><ArticleId IdType="pubmed">35124947</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliam S, Riordan A. How to use: c-reactive protein. Arch Dis Child Educ Pract Ed. 2010;95(2):55–58. doi:10.1136/adc.2009.174367</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2009.174367</ArticleId><ArticleId IdType="pubmed">20351152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei S, Wang L, Lin L, Liu X. Predictive values of procalcitonin for coinfections in patients with COVID-19: a systematic review and meta-analysis. Virol J. 2023;20(1):92. doi:10.1186/s12985-023-02042-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02042-x</ArticleId><ArticleId IdType="pmc">PMC10166029</ArticleId><ArticleId IdType="pubmed">37158904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganda IJ, Putri TKE, Rauf S, et al. IL-6 serum level, ARDS, and AKI as risk factors for the COVID-19 infection’s mortality in children. PLoS One. 2023;18(10):e0293639. doi:10.1371/journal.pone.0293639</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0293639</ArticleId><ArticleId IdType="pmc">PMC10610523</ArticleId><ArticleId IdType="pubmed">37889917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazi MA, Roychowdhury S, Ghosh S, et al. Characteristics and predictors of outcomes of critically Ill children with SARS-CoV-2 infection - the PICU experience. J Pediatr. 2022;98(5):504–512. doi:10.1016/j.jped.2021.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2021.12.006</ArticleId><ArticleId IdType="pmc">PMC8801309</ArticleId><ArticleId IdType="pubmed">35139344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui-Binh-Bao S, Nguyen-Thi-My T, Nguyen-Duy-Nam A, Kim Hoa NT, Pham-Van D. Is serum lactate a good predictor of mortality in children aged 2 months to 5 years with pneumonia in central Vietnam. Glob Pediatr Health. 2021;8:2333794X211060806. doi:10.1177/2333794X211060806</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2333794X211060806</ArticleId><ArticleId IdType="pmc">PMC8637374</ArticleId><ArticleId IdType="pubmed">34869798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikura H, Maruyama J, Nakashio M, et al. Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19). Int J Hematol. 2023;117(6):845–855. doi:10.1007/s12185-023-03555-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-023-03555-5</ArticleId><ArticleId IdType="pmc">PMC10016182</ArticleId><ArticleId IdType="pubmed">36920687</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>